Related Experiment Video
Updated: Nov 30, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
USP25 Regulates EGFR Fate by Modulating EGF-Induced Ubiquitylation Dynamics
Carlos A Niño1, Nadine Wollscheid1, Giovanni Giangreco2
1IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20139 Milan, Italy.
Abstract:
Deregulated epidermal growth factor receptor (EGFR) signaling is a key feature in different stages of oncogenesis. One important mechanism whereby cancer cells achieve increased and uncontrolled EGFR signaling is escaping down-modulation of the receptor. Ubiquitylation of the EGFR plays a decisive role in this process, as it regulates receptor internalization, trafficking and degradation. Deubiquitinating enzymes (DUBs) may oppose the ubiquitylation process, antagonizing or even promoting receptor degradation. Here, we use qualitative and quantitative assays to measure EGFR internalization and degradation after Ubiquitin Specific Peptidase 25 (USP25) depletion. We show that, by acting at the early steps of EGFR internalization, USP25 restrains the degradation of the EGFR by assisting in the association of the E3 ubiquitin ligase c-Cbl with EGFR, thereby modulating the amplitude of ubiquitylation on the receptor. This study establishes USP25 as a negative regulator of the EGFR down-modulation process and suggests that it is a promising target for pharmacological intervention to hamper oncogenic growth signals in tumors that depend on the EGFR.
Insights
Ubiquitin Specific Peptidase 25 (USP25) restrains epidermal growth factor receptor (EGFR) degradation by regulating its internalization. USP25 acts as a negative regulator, suggesting it
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Deregulated epidermal growth factor receptor (EGFR) signaling drives oncogenesis.
- Cancer cells evade EGFR down-modulation to sustain uncontrolled signaling.
- Ubiquitylation of EGFR is crucial for its internalization, trafficking, and degradation.
Purpose of the Study:
- To investigate the role of Ubiquitin Specific Peptidase 25 (USP25) in EGFR regulation.
- To determine USP25's impact on EGFR internalization and degradation.
- To assess USP25 as a potential therapeutic target for EGFR-dependent tumors.
Main Methods:
- Qualitative and quantitative assays were employed.
- EGFR internalization and degradation were measured following USP25 depletion.
- The association between USP25, c-Cbl, and EGFR was analyzed.
Main Results:
- USP25 depletion significantly altered EGFR internalization and degradation.
- USP25 restrains EGFR degradation by facilitating c-Cbl E3 ligase association with EGFR.
- USP25 modulates the amplitude of EGFR ubiquitylation at early internalization steps.
Conclusions:
- USP25 acts as a negative regulator of EGFR down-modulation.
- USP25's mechanism involves modulating EGFR ubiquitylation and c-Cbl association.
- USP25 represents a promising therapeutic target to inhibit oncogenic EGFR signaling.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
Abnormal Proliferation

